Biological/Vaccine: Placebo

BIOLOGICAL2 trials

Sponsors

HAL Allergy, Joseph Broderick, MD

Conditions

House Dust Mite AllergyHouse Dust Mite RhinitisIntracerebral Hemorrhage

Phase 3

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

CompletedNCT06920771

HAL AllergyHouse Dust Mite Allergy, House Dust Mite Rhinitis

Start: 2024-09-09End: 2026-03-30Updated: 2026-08-10

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

RecruitingNCT07227246

Joseph Broderick, MDIntracerebral Hemorrhage

Start: 2025-05-06End: 2029-06-01Target: 350Updated: 2026-08-20